Author

D. Kuo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Accelerating Medicines Partnership RA/SLE Network· 1 shared B. Zhang· 1 shared C. Rozo· 1 shared D. Rao· 1 shared E. F. DiCarlo· 1 shared F. Zhang· 1 shared G. Rätsch· 1 shared H. T. Maecker· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Accelerating Medicines Partnership RA/SLE Network

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cross-platform comparison of highly-sensitive immunoassays for inflammatory markers in a COVID-19 cohort

K. Abe, J. C. Beer, T. Nguyen, I. S. Ariyapala, T. H. Holmes, W. Feng, B. Zhang, D. Kuo, Y. Luo, X.-J. Ma, H. T. Maecker

This study compares three immunoassay platforms for inflammatory markers in a COVID-19 cohort, finding differences in detectability, correlation, and differential expression.

bioRxiv · Oct 24, 2023 · PreprintImmunology

HBEGF+ macrophages identified in rheumatoid arthritis promote joint tissue invasiveness and are reshaped differentially by medications

D. Kuo, J. Ding, I. Cohn, F. Zhang, K. Wei, D. Rao, C. Rozo, U. K. Sokhi, Accelerating Medicines Partnership RA/SLE Network, E. F. DiCarlo, M. B. Brenner, V. P. Bykerk, S. M. Goodman, S. Raychaudhuri, G. Rätsch, , L. T. Donlin

A newly identified human macrophage phenotype in RA promotes joint tissue invasiveness and shows variable responses to anti-inflammatory medications.

bioRxiv · Jan 31, 2019 · PreprintImmunology